FARMINGDALE, NY  --  Enzo Biochem, Inc. (NYSE: ENZ) announced today that Hamid Erfanian, Chief Executive Officer (CEO), will be resigning his seat on the Board of Directors and departing the Company effective September 5, 2023, with Enzo’s Chief Operating Officer, Kara Cannon, assuming the role of interim CEO. “We thank Hamid for the commitment he [...]

Devyser and Thermo Fisher Scientific have agreed to expand commercial collaboration by including Brazil in the exclusive collaboration and distribution agreement for Devyser's post-transplant portfolio of NGS products. In addition to North America and Europe, Thermo Fisher will now exclusively market and sell Devyser's transplantation products under combined brands also in Brazil.   "We are very [...]

Espoo, Finland. Euformatics, a world leader in NGS quality control and variant interpretation tools, announced that it has signed a new commercial relationship with Cerba, world reference laboratory in specialized clinical pathology. As part of the collaboration, Euformatics delivers the full Genomics Hub software suite to Cerba to power their NGS test validation, continuous quality [...]

Business momentum propelled by U.S. and international expansion SAN DIEGO, CA – Element Biosciences, Inc., developer of the Element AVITI™ System, an innovative DNA sequencing platform that is disrupting the genomics industry, today announced it has exceeded 100 orders of the AVITI System. With U.S. and international customers in 13 countries, Element has expanded its commercial team [...]

CHARLOTTESVILLE, Va. --LumaCyte, an advanced bioanalytical instrumentation leader for rapid label-free cellular analytics, today announced the closing of a B series financing that will further accelerate growth in the company’s automated bioproduction analytics solutions and expand its global infrastructure to meet growing demand. The financing was led by Malvern Panalytical, an international leader in advanced scientific [...]

Breakthrough platform delivers process flexibility and scalability with the first active release mechanism of its kind for clinical trial and commercial manufacturing use WALTHAM, Mass.– Thermo Fisher Scientific Inc., the world leader in serving science, today announced the Gibco CTS Detachable Dynabeads (CTS Detachable Dynabeads)*, its next-generation platform of Dynabeads with the first active release mechanism of its [...]

HALLE (SAALE), Germany and BARCELONA, Spain -- We are excited to announce a pioneering partnership between Nostrum Biodiscovery, a frontrunner in computational molecular engineering services, and Navigo Proteins, an innovator developing next generation targeting ligands called Affilin®. Navigo and Nostrum recently joined forces to co-develop a new cutting-edge pipeline of de novo designed ubiquitin-based Affilin® ligands, expanding Navigo’s proprietary Affilin® [...]

Partnership to provide customers with direct access to portfolio of highly characterized hepatic cells to recreate advanced Liver-on-a-Chip assays Pre-validated cells alleviate the need for stringent in-house quality control testing to maximize assay success Cambridge, UK: CN Bio, a leading Organ-on-a-Chip (OOC) company that designs and manufactures single-and multi-organ microphysiological systems (MPS), and LifeNet Health LifeSciences, “LifeNet Health”, [...]

Exclusive partnership will provide access for customers in China to iotaSciences proprietary single cell handling platforms based on its proprietary fluid-shaping technology Oxford (UK): iotaSciences, the Oxford-based leader in the rapidly growing field of single-cell handling solutions, and Quantum Design China, a subsidiary of Quantum Design International, announced today an exclusive distribution agreement for iotaSciences [...]

ROCKVILLE, Md. -- MaxCyte, Inc., (Nasdaq: MXCT; LSE: MXCT), a leading, cell-engineering focused company providing enabling platform technologies to advance the discovery, development and commercialization of next-generation cell-based therapeutics and to support innovative, cell-based research, today announced the appointment of Ali Soleymannezhad as Executive Vice President of Bioprocessing, effective August 21, 2023. Mr. Soleymannezhad will [...]